Merck & Co., Inc.
Merck & Co., Inc. 6MK.DE Peers
See (6MK.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6MK.DE | €70.20 | +0.43% | 176.3B | 11.70 | €6.00 | +4.23% |
| LLY.DE | €659.70 | -1.26% | 625.2B | 62.65 | €10.53 | +0.73% |
| JNJ.DE | €132.34 | -0.74% | 318.4B | 17.21 | €7.69 | +3.54% |
| 4AB.DE | €163.20 | +0.74% | 288.3B | 80.39 | €2.03 | +3.69% |
| ZEG.DE | €120.70 | -0.66% | 187.2B | 28.00 | €4.31 | +2.27% |
| AMG.DE | €252.70 | +6.38% | 135.9B | 26.49 | €9.54 | +3.35% |
| PFE.DE | €21.48 | +0.68% | 122.1B | 17.90 | €1.20 | +7.49% |
| PFE.F | €21.48 | +0.89% | 121.8B | 17.71 | €1.21 | +7.50% |
| GIS.DE | €95.64 | +1.39% | 119B | 23.10 | €4.14 | +3.06% |
| SNW.DE | €83.61 | +0.64% | 101.9B | 16.76 | €4.99 | +4.69% |
Stock Comparison
6MK.DE vs LLY.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, LLY.DE has a market cap of 625.2B. Regarding current trading prices, 6MK.DE is priced at €70.20, while LLY.DE trades at €659.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas LLY.DE's P/E ratio is 62.65. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs JNJ.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, JNJ.DE has a market cap of 318.4B. Regarding current trading prices, 6MK.DE is priced at €70.20, while JNJ.DE trades at €132.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas JNJ.DE's P/E ratio is 17.21. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, 6MK.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs 4AB.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, 4AB.DE has a market cap of 288.3B. Regarding current trading prices, 6MK.DE is priced at €70.20, while 4AB.DE trades at €163.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas 4AB.DE's P/E ratio is 80.39. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, 6MK.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs ZEG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, ZEG.DE has a market cap of 187.2B. Regarding current trading prices, 6MK.DE is priced at €70.20, while ZEG.DE trades at €120.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas ZEG.DE's P/E ratio is 28.00. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, 6MK.DE is less volatile compared to ZEG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs AMG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, AMG.DE has a market cap of 135.9B. Regarding current trading prices, 6MK.DE is priced at €70.20, while AMG.DE trades at €252.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas AMG.DE's P/E ratio is 26.49. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, 6MK.DE is less volatile compared to AMG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, PFE.DE has a market cap of 122.1B. Regarding current trading prices, 6MK.DE is priced at €70.20, while PFE.DE trades at €21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas PFE.DE's P/E ratio is 17.90. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.F Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, PFE.F has a market cap of 121.8B. Regarding current trading prices, 6MK.DE is priced at €70.20, while PFE.F trades at €21.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas PFE.F's P/E ratio is 17.71. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GIS.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, GIS.DE has a market cap of 119B. Regarding current trading prices, 6MK.DE is priced at €70.20, while GIS.DE trades at €95.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas GIS.DE's P/E ratio is 23.10. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, 6MK.DE is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs SNW.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, SNW.DE has a market cap of 101.9B. Regarding current trading prices, 6MK.DE is priced at €70.20, while SNW.DE trades at €83.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas SNW.DE's P/E ratio is 16.76. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, 6MK.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BRM.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, BRM.DE has a market cap of 83.3B. Regarding current trading prices, 6MK.DE is priced at €70.20, while BRM.DE trades at €40.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas BRM.DE's P/E ratio is 17.56. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, 6MK.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.SG Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, BAYN.SG has a market cap of 25.9B. Regarding current trading prices, 6MK.DE is priced at €70.20, while BAYN.SG trades at €26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, BAYN.DE has a market cap of 25.9B. Regarding current trading prices, 6MK.DE is priced at €70.20, while BAYN.DE trades at €26.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas BAYN.DE's P/E ratio is -7.94. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs IDP.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, IDP.DE has a market cap of 16.7B. Regarding current trading prices, 6MK.DE is priced at €70.20, while IDP.DE trades at €114.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas IDP.DE's P/E ratio is 13.18. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GS7.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 176.3B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, 6MK.DE is priced at €70.20, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.70, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.